The COVID-19 pandemic has affected and impacted our lives in a totally unprecedented way. Millions of people around the world have been infected, leaving hundreds of thousands of people dead. In the Philippines, we have more than 14,000 total confirmed cases and close to 900 deaths because of this pandemic.
This Wednesday morning, May 27, a webinar zoom event was held as "Kapihan sa Manila Bay" with Marichu Villanueva, who hosts its first-ever kapihan online with the topic: AFTER THE COVID-19 CONTAGION, HOW CAN THE PHILIPPINES PREPARE BETTER FOR ANY FUTURE PANDEMIC?
The panelists were Congresswoman Angelina Tan, Chairperson, Committee on Health, House of Representatives, Congressman Adriano Ebcas, AKO PADAYON Pilipino party-list representative, Health Undersecretary Rosario Vergeire, Public Health Epidemiologist Dr. Troy Gepte and Dr. Lulu Bravo, Executive Director, Philippine Foundation for Vaccination.
Tan cited the importance of pursuing the government’s immunization program even during the community quarantine as a way to ensure that children are protected from future pandemics.
“We have several initiatives in Congress in relation to the country’s immunization program,” Tan revealed. “We are pushing for the creation of the NITAG, a national immunization advisory board, and we are trying to adopt a school-based immunization program that will benefit our students,” she added.
Tan also reaffirmed her call for an open, competitive bidding process in vaccines. According to Tan, an important element in the immunization program is to ensure that the procurement of vaccines is done in such a way that no single manufacturer is favored. The specifications in bidding should not favor a single brand.
Health Undersecretary Dr. Ma. Rosario Vergeire explained in the same forum that the DOH suspended the bidding for PCVs after new evidence that they need to look into more carefully was presented.
“Nung lumabas ang bagong ebidensiya na sinubmit sa atin, ang desisyon namin ay ipasok muna sa Health Technology Assessment Center (HTAC). HTAC is reviewing the procurement, which is really the right process. Ngayon po hindi pa lumalabas ang recommendation ng HTAC,” Vergeire revealed.
The DOH previously requested the HTAC to review the National Immunization Program (NIP), particularly the Pneumococcal Vaccination Program for children, in light of new 2017 and 2019 evidence from the World Health Organization (WHO).
In February 2019, WHO reaffirmed this earlier position saying that the two available PCVs in the market--PCV10 and PCV13--are equally effective in preventing overall pneumococcal diseases in children. The position paper also states that there is at present insufficient evidence of a difference in the net impact of the two available PCVs on overall disease burden.
During the Kapihan webinar zoom meeting, Dr. Lulu Bravo, an epidemiologist, and professor of Pediatric Infectious and Tropical Diseases at the College of Medicine of UP Manila stressed that the new evidence regarding PCVs that came out recently came from experts themselves.
“According to the WHO, when it comes to pneumococcal vaccination for children, both PCV10 and PCV13 are just as good. The important thing is cost-effectiveness,” Bravo noted.
“We should follow what the WHO says, being experts in their field. If you cannot believe WHO, who will you believe?” she added
“Both vaccines exist. If the health assessment proves that both PCV10 and PCV13 have the same effects, then we need to go through a procurement process that’s open and competitive so the government can save on costs,” Tan said.
On a related note, Rep. Adriano A. Ebcas of the Ako Padayon Pilipino Partylist revealed that he and three other partylist representatives filed a resolution urging the DOH to ensure the continued safe implementation of the mandated National Immunization Program for children despite the challenges posed by the COVID-19 pandemic.
The House Resolution aims to encourage and support the DOH in its endeavor to contain the current outbreak and prevent future community outbreaks of vaccine-preventable diseases (VPDs) during the COVID-19 pandemic.
The resolution also aims to secure and ensure a stable supply of available vaccines through the continued conduct of open, fair, and competitive bidding, thereby preventing any “outbreak within an outbreak.”
In the resolution, the solons declared,
“An open, fair, competitive public procurement of NIP vaccines provide the Filipino people the broadest possible options for affordable, quality, and registered vaccines, allowing for potential significant savings to the government while at the same promoting strong public governance.”
No comments:
Post a Comment